Dr. Hiddo J.L. Heerspink benefitted from a rapid consideration and peer-review process to publish his LBCT article simultaneously with his presentation at #ERA24. Submit your LBCT manuscript to JASN for potential concurrent publication with #ERA25 #ASNJASN bit.ly/JASNLBCT
March 19, 2025 at 5:30 PM
Dr. Hiddo J.L. Heerspink benefitted from a rapid consideration and peer-review process to publish his LBCT article simultaneously with his presentation at #ERA24. Submit your LBCT manuscript to JASN for potential concurrent publication with #ERA25 #ASNJASN bit.ly/JASNLBCT
Happy #FLOW trial publication day to all who celebrate 🎉
Effects of Semaglutide on CKD in Pts w/ DMT2 @NEJM
Reduction in:
Primary composite kidney outcomes 🥊
GFR slope 🥊
CV Death 🥊
All cause death 🥊
@hswapnil.bsky.social #ERA24 #NephSky www.nejm.org/doi/full/10....
Effects of Semaglutide on CKD in Pts w/ DMT2 @NEJM
Reduction in:
Primary composite kidney outcomes 🥊
GFR slope 🥊
CV Death 🥊
All cause death 🥊
@hswapnil.bsky.social #ERA24 #NephSky www.nejm.org/doi/full/10....
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes | NEJM
Patients with type 2 diabetes and chronic kidney disease are at high risk for kidney
failure, cardiovascular events, and death. Whether treatment with semaglutide would
mitigate these risks is unkn...
www.nejm.org
May 24, 2024 at 8:28 PM
Happy #FLOW trial publication day to all who celebrate 🎉
Effects of Semaglutide on CKD in Pts w/ DMT2 @NEJM
Reduction in:
Primary composite kidney outcomes 🥊
GFR slope 🥊
CV Death 🥊
All cause death 🥊
@hswapnil.bsky.social #ERA24 #NephSky www.nejm.org/doi/full/10....
Effects of Semaglutide on CKD in Pts w/ DMT2 @NEJM
Reduction in:
Primary composite kidney outcomes 🥊
GFR slope 🥊
CV Death 🥊
All cause death 🥊
@hswapnil.bsky.social #ERA24 #NephSky www.nejm.org/doi/full/10....
November 22, 2024 at 9:14 AM
How can we balance the risk of infection versus the risk of under-treatment facilitating disease progression or relapse in GN (AAV given as example)?
✅ Screening
✅Rx optimisation
✅Antibiotic prophylaxis
✅Monitoring for AEs
✅Vaccination
From @odlerb
#ERA24
✅ Screening
✅Rx optimisation
✅Antibiotic prophylaxis
✅Monitoring for AEs
✅Vaccination
From @odlerb
#ERA24
November 22, 2024 at 9:14 AM
How can we balance the risk of infection versus the risk of under-treatment facilitating disease progression or relapse in GN (AAV given as example)?
✅ Screening
✅Rx optimisation
✅Antibiotic prophylaxis
✅Monitoring for AEs
✅Vaccination
From @odlerb
#ERA24
✅ Screening
✅Rx optimisation
✅Antibiotic prophylaxis
✅Monitoring for AEs
✅Vaccination
From @odlerb
#ERA24
November 22, 2024 at 9:09 AM
.@IgAN_JBarratt says that for much of past 20 years trial landscape in IgAN has been 🌵resembling the sole remaining glomerulus in patients with IgAN.
This has been transformed by academic nephrologists and community pushing for change.
#ERA24
This has been transformed by academic nephrologists and community pushing for change.
#ERA24
November 22, 2024 at 9:09 AM
.@IgAN_JBarratt says that for much of past 20 years trial landscape in IgAN has been 🌵resembling the sole remaining glomerulus in patients with IgAN.
This has been transformed by academic nephrologists and community pushing for change.
#ERA24
This has been transformed by academic nephrologists and community pushing for change.
#ERA24
November 22, 2024 at 9:09 AM
Prof Floege advises his GN patients that they have two diseases, that they have an immune mediated kidney disease that can seriously affect kidney function and that they have chronic kidney disease. #ERA24
November 22, 2024 at 9:04 AM
Prof Floege advises his GN patients that they have two diseases, that they have an immune mediated kidney disease that can seriously affect kidney function and that they have chronic kidney disease. #ERA24
#ERA24 Plenary from @BNHorowitzMD
By moving beyond humans and disease models can we improve our understanding of the causes of disease and improve biomedical innovation?
By moving beyond humans and disease models can we improve our understanding of the causes of disease and improve biomedical innovation?
November 22, 2024 at 9:04 AM
#ERA24 Plenary from @BNHorowitzMD
By moving beyond humans and disease models can we improve our understanding of the causes of disease and improve biomedical innovation?
By moving beyond humans and disease models can we improve our understanding of the causes of disease and improve biomedical innovation?
November 22, 2024 at 9:04 AM
November 22, 2024 at 9:04 AM
🤰🫘
@ClionaCowhig @sarah_m_moran @russellnoirin @HMiremberg
52 respondents, most working as nephrologists in clinical practice
11 European countries represented
Preconception care by general nephrologists
Equal care from general + specialist obs nephrologists during🤰
#ERA24
@ClionaCowhig @sarah_m_moran @russellnoirin @HMiremberg
52 respondents, most working as nephrologists in clinical practice
11 European countries represented
Preconception care by general nephrologists
Equal care from general + specialist obs nephrologists during🤰
#ERA24
November 22, 2024 at 9:04 AM
🤰🫘
@ClionaCowhig @sarah_m_moran @russellnoirin @HMiremberg
52 respondents, most working as nephrologists in clinical practice
11 European countries represented
Preconception care by general nephrologists
Equal care from general + specialist obs nephrologists during🤰
#ERA24
@ClionaCowhig @sarah_m_moran @russellnoirin @HMiremberg
52 respondents, most working as nephrologists in clinical practice
11 European countries represented
Preconception care by general nephrologists
Equal care from general + specialist obs nephrologists during🤰
#ERA24
Interesting observational cohort study on long-term outcomes from biopsy proven AIN
Significant morbidity and mortality in first year post diagnosis
From @Kevinlyttle1 @ClionaCowhig @_JamesGleeson @sarah_m_moran @MikeClarkson99 et al
#ERA24
Significant morbidity and mortality in first year post diagnosis
From @Kevinlyttle1 @ClionaCowhig @_JamesGleeson @sarah_m_moran @MikeClarkson99 et al
#ERA24
November 22, 2024 at 8:58 AM
Interesting observational cohort study on long-term outcomes from biopsy proven AIN
Significant morbidity and mortality in first year post diagnosis
From @Kevinlyttle1 @ClionaCowhig @_JamesGleeson @sarah_m_moran @MikeClarkson99 et al
#ERA24
Significant morbidity and mortality in first year post diagnosis
From @Kevinlyttle1 @ClionaCowhig @_JamesGleeson @sarah_m_moran @MikeClarkson99 et al
#ERA24
✈️ At ERA24, travel = 89% of all CO₂e.
👥 7,187 attendees
🌍 65M km travelled (≈1,627 Earth trips!)
Measuring the full footprint is the first step toward change.
👥 7,187 attendees
🌍 65M km travelled (≈1,627 Earth trips!)
Measuring the full footprint is the first step toward change.
December 22, 2025 at 7:52 AM
✈️ At ERA24, travel = 89% of all CO₂e.
👥 7,187 attendees
🌍 65M km travelled (≈1,627 Earth trips!)
Measuring the full footprint is the first step toward change.
👥 7,187 attendees
🌍 65M km travelled (≈1,627 Earth trips!)
Measuring the full footprint is the first step toward change.
Pop along & visit the journals just beside the artwork for NDT’s cover - you can meet Prof Floege now & @hjanders_hans later today!
Plus have your pic taken for the cover 😉
#ERA24
Plus have your pic taken for the cover 😉
#ERA24
November 16, 2024 at 9:02 AM
Pop along & visit the journals just beside the artwork for NDT’s cover - you can meet Prof Floege now & @hjanders_hans later today!
Plus have your pic taken for the cover 😉
#ERA24
Plus have your pic taken for the cover 😉
#ERA24
15/ Quick selfie with @kirkcampbell campbell, remember the last one on il domo top in Milan , after @erakidney ended. Next time hope will have @aishaikh and the guys. Maybe Sweden, find an iconic place, make it a landmark for all the congresses will bump into each other? #era24
November 17, 2024 at 12:18 AM
15/ Quick selfie with @kirkcampbell campbell, remember the last one on il domo top in Milan , after @erakidney ended. Next time hope will have @aishaikh and the guys. Maybe Sweden, find an iconic place, make it a landmark for all the congresses will bump into each other? #era24
